Trial intelligence / Profile preview

Median Local Anaesthetic Dose of Intrathecal Bupivacaine in Anterior Approach Total Hip Arthroplasty

2015-002958-12Phase 4Active

Sponsor
Reinier de Graaf Hospital
Start
Jul 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of bupivacaine in None, sponsored by Reinier de Graaf Hospital. Primary endpoint: Primary endpoint: Motor and sensory recovery at 119 minutes. Started Jul 2015; status: active.

02

Drugs

bupivacaine

Beyond the preview

Go deeper on 2015-002958-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-002958-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call